The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-06-22
DOI
10.3389/fneur.2021.674483
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Responsive Vagus Nerve Stimulation for Drug Resistant Epilepsy: A Review of New Features and Practical Guidance for Advanced Practice Providers
- (2021) Breanne Fisher et al. Frontiers in Neurology
- Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program
- (2021) Manuela Contin et al. Frontiers in Pharmacology
- Inflammation in pediatric epilepsies: Update on clinical features and treatment options
- (2021) Tiziana Granata et al. EPILEPSY & BEHAVIOR
- Corrigendum to “Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018)” [Clin. Neurophysiol. 131 (2020) 474–528]
- (2020) Jean-Pascal Lefaucheur et al. CLINICAL NEUROPHYSIOLOGY
- Dravet syndrome: Treatment options and management of prolonged seizures
- (2020) J. Helen Cross et al. EPILEPSIA
- Perampanel tolerability in children and adolescents with focal epilepsy: Effects on behavior and executive functions
- (2020) Francesca Felicia Operto et al. EPILEPSY & BEHAVIOR
- What are the challenges with the pharmacological management of epilepsy in patients with Attention Deficit Hyperactivity Disorder (ADHD)?
- (2020) Sara Matricardi et al. EXPERT OPINION ON PHARMACOTHERAPY
- Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome
- (2020) Ian Miller et al. JAMA Neurology
- Cannabidiol efficacy and clobazam status: A systematic review and meta‐analysis
- (2020) Simona Lattanzi et al. EPILEPSIA
- Cannabidiol efficacy independent of clobazam: Meta‐analysis of four randomized controlled trials
- (2020) Orrin Devinsky et al. ACTA NEUROLOGICA SCANDINAVICA
- Evidence-based guidelines and secondary meta-analysis for the use of transcranial direct current stimulation (tDCS) in neurological and psychiatric disorders
- (2020) Felipe Fregni et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy
- (2020) Dileep R Nair et al. NEUROLOGY
- Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options
- (2020) Wolfgang Löscher et al. PHARMACOLOGICAL REVIEWS
- Potential role of brivaracetam in pediatric epilepsy
- (2020) Alberto Verrotti et al. ACTA NEUROLOGICA SCANDINAVICA
- Fenfluramine for the Treatment of Dravet Syndrome and Lennox–Gastaut Syndrome
- (2020) Ganna Balagura et al. CNS DRUGS
- Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long‐term open‐label safety extension study
- (2020) Wyman W. Lai et al. EPILEPSIA
- Diet in the Treatment of Epilepsy: What We Know So Far
- (2020) Alberto Verrotti et al. Nutrients
- Novel therapeutic options for Dravet and Lennox-Gastaut syndrome
- (2020) Alberto Verrotti et al. Expert Review of Neurotherapeutics
- The Ketogenic Diet for the Treatment of Mood Disorders in Comorbidity With Epilepsy in Children and Adolescents
- (2020) Francesca Felicia Operto et al. Frontiers in Pharmacology
- A Practical Guide to Treatment of Childhood Absence Epilepsy
- (2019) Sudha Kilaru Kessler et al. PEDIATRIC DRUGS
- Identifying mutations in epilepsy genes: Impact on treatment selection
- (2019) Piero Perucca et al. EPILEPSY RESEARCH
- Responsive Neurostimulation for the Treatment of Epilepsy
- (2019) Caio M. Matias et al. NEUROSURGERY CLINICS OF NORTH AMERICA
- Transcranial Direct Current Stimulation Reduces Seizure Frequency in Patients with Refractory Focal Epilepsy: A Randomized, Double-blind, Sham-controlled, and Three-arm Parallel Multicenter Study
- (2019) Dongju Yang et al. Brain Stimulation
- Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions
- (2019) Lyndsey L. Anderson et al. EPILEPSIA
- Clinical opinion: Earlier employment of polytherapy in sequential pharmacotherapy of epilepsy
- (2019) Byung In Lee et al. EPILEPSY RESEARCH
- A Review of Neurostimulation for Epilepsy in Pediatrics
- (2019) Keith Starnes et al. Brain Sciences
- Trends in pediatric epilepsy surgery in Europe between 2008 and 2015: Country‐, center‐, and age‐specific variation
- (2019) Carmen Barba et al. EPILEPSIA
- The role of polytherapy in the management of epilepsy: suggestions for rational antiepileptic drug selection
- (2019) Alberto Verrotti et al. Expert Review of Neurotherapeutics
- Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial
- (2019) Lieven Lagae et al. LANCET
- Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial
- (2019) Gregory L Krauss et al. LANCET NEUROLOGY
- Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens
- (2019) Rima Nabbout et al. JAMA Neurology
- Understanding Childhood Neuroimmune Diseases of the Central Nervous System
- (2019) Sara Matricardi et al. Frontiers in Pediatrics
- Palliative non-resective surgery for drug-resistant epilepsy
- (2018) Simona Lattanzi et al. BRAIN & DEVELOPMENT
- Neurostimulation for drug-resistant epilepsy
- (2018) Paul Boon et al. CURRENT OPINION IN NEUROLOGY
- Inflammation and Epilepsy: Preclinical Findings and Potential Clinical Translation
- (2018) Gaetano Terrone et al. CURRENT PHARMACEUTICAL DESIGN
- Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307
- (2018) Gregory L. Krauss et al. EPILEPSIA
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
- (2018) Orrin Devinsky et al. NEUROLOGY
- Pharmacogenomics in epilepsy
- (2018) Simona Balestrini et al. NEUROSCIENCE LETTERS
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs
- (2018) Zhibin Chen et al. JAMA Neurology
- Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development
- (2018) Meir Bialer et al. EPILEPSIA
- The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis
- (2018) Linda Kalilani et al. EPILEPSIA
- Long-term cannabidiol treatment in patients with Dravet syndrome: An open-label extension trial
- (2018) Orrin Devinsky et al. EPILEPSIA
- Emerging drugs for the treatment of Dravet syndrome
- (2018) Francesco Brigo et al. EXPERT OPINION ON EMERGING DRUGS
- The pharmacological management of Lennox-Gastaut syndrome and critical literature review
- (2018) Alberto Verrotti et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Brain-responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy
- (2017) Eric B. Geller et al. EPILEPSIA
- Deep brain stimulation for drug-resistant epilepsy
- (2017) Michael C. H. Li et al. EPILEPSIA
- Neuroinflammatory targets and treatments for epilepsy validated in experimental models
- (2017) Eleonora Aronica et al. EPILEPSIA
- Epilepsy treatment in adults and adolescents: Expert opinion, 2016
- (2017) Jerry J. Shih et al. EPILEPSY & BEHAVIOR
- Chronic subthreshold cortical stimulation: a therapeutic and potentially restorative therapy for focal epilepsy
- (2017) Brian Nils Lundstrom et al. Expert Review of Neurotherapeutics
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel
- (2017) Elaine C. Wirrell et al. PEDIATRIC NEUROLOGY
- Epilepsy-associated genes
- (2017) Jie Wang et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Childhood absence epilepsy and benign epilepsy with centro-temporal spikes: a narrative review analysis
- (2017) Alberto Verrotti et al. World Journal of Pediatrics
- Chronic subthreshold cortical stimulation: a therapeutic and potentially restorative therapy for focal epilepsy
- (2017) Brian Nils Lundstrom et al. Expert Review of Neurotherapeutics
- Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers
- (2017) Fei Tang et al. Frontiers in Neurology
- Pharmacological Treatment of Drug-Resistant Epilepsy in Adults: a Practical Guide
- (2016) Martin J. Brodie Current Neurology and Neuroscience Reports
- Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients
- (2016) A. Schoonjans et al. EUROPEAN JOURNAL OF NEUROLOGY
- Comorbidities of epilepsy: current concepts and future perspectives
- (2016) Mark R Keezer et al. LANCET NEUROLOGY
- Cognitive and neurodevelopmental comorbidities in paediatric epilepsy
- (2016) Katherine C. Nickels et al. Nature Reviews Neurology
- Brivaracetam add-on for refractory focal epilepsy
- (2016) Simona Lattanzi et al. NEUROLOGY
- Low and High Frequency Hippocampal Stimulation for Drug-Resistant Mesial Temporal Lobe Epilepsy
- (2016) Siew-Na Lim et al. NEUROMODULATION
- Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
- (2015) Alexandra L. Geffrey et al. EPILEPSIA
- Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics
- (2015) Jo M. Wilmshurst et al. EPILEPSIA
- Refractory absence seizures: An Italian multicenter retrospective study
- (2015) Emilio Franzoni et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy
- (2015) V. Salanova et al. NEUROLOGY
- Long-term treatment with responsive brain stimulation in adults with refractory partial seizures
- (2015) G. K. Bergey et al. NEUROLOGY
- Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy
- (2015) Jacqueline A. French et al. NEUROLOGY
- Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome
- (2015) An-Sofie Schoonjans et al. Therapeutic Advances in Neurological Disorders
- Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)
- (2014) Jean-Pascal Lefaucheur et al. CLINICAL NEUROPHYSIOLOGY
- Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: Results from phase III extension study 307
- (2014) Gregory L. Krauss et al. EPILEPSIA
- Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: Final results of the RNS System Pivotal trial
- (2014) Christianne N. Heck et al. EPILEPSIA
- The detection of neural autoantibodies in patients with antiepileptic-drug-resistant epilepsy predicts response to immunotherapy
- (2014) R. Iorio et al. EUROPEAN JOURNAL OF NEUROLOGY
- Refractory Absence Epilepsy and Glut1 Deficiency Syndrome: A New Case Report and Literature Review
- (2014) Francesca Ragona et al. NEUROPEDIATRICS
- Basic mechanisms of antiepileptic drugs and their pharmacokinetic/pharmacodynamic interactions: an update
- (2014) Władysław Lasoń et al. Pharmacological Reports
- Effectiveness of Antiepileptic Drug Combination Therapy for Partial-Onset Seizures Based on Mechanisms of Action
- (2014) Jay M. Margolis et al. JAMA Neurology
- Improved outcomes with earlier surgery for intractable frontal lobe epilepsy
- (2013) Thitiwan Simasathien et al. ANNALS OF NEUROLOGY
- The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs
- (2013) Michael A. Rogawski EPILEPSIA
- Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
- (2013) Tracy Glauser et al. EPILEPSIA
- Deep brain stimulation of the centromedian thalamic nucleus for the treatment of generalized and frontal epilepsies
- (2013) Antonio Valentín et al. EPILEPSIA
- When one plus one makes three: The quest for rational antiepileptic polytherapy with supraadditive anticonvulsant efficacy
- (2013) Francesco Brigo et al. EPILEPSY & BEHAVIOR
- Evidence-based guideline update: Vagus nerve stimulation for the treatment of epilepsy: Report of the Guideline Development Subcommittee of the American Academy of Neurology
- (2013) G. L. Morris et al. NEUROLOGY
- Inflammatory pathways of seizure disorders
- (2013) Nicola Marchi et al. TRENDS IN NEUROSCIENCES
- Vagus nerve stimulation in children with intractable epilepsy: a randomized controlled trial
- (2012) SYLVIA KLINKENBERG et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305
- (2012) Jacqueline A. French et al. EPILEPSIA
- Successful use of fenfluramine as an add-on treatment for Dravet syndrome
- (2012) Berten Ceulemans et al. EPILEPSIA
- Adjunctive perampanel for refractory partial-onset seizures: Randomized phase III study 304
- (2012) J. A. French et al. NEUROLOGY
- Randomized phase III study 306: Adjunctive perampanel for refractory partial-onset seizures
- (2012) G. L. Krauss et al. NEUROLOGY
- Patterns of treatment response in newly diagnosed epilepsy
- (2012) M. J. Brodie et al. NEUROLOGY
- Remission and relapse in a drug-resistant epilepsy population followed prospectively
- (2011) Brian Callaghan et al. EPILEPSIA
- A new hypothesis of drug refractory epilepsy: Neural network hypothesis
- (2011) Min Fang et al. MEDICAL HYPOTHESES
- Drug-Resistant Epilepsy
- (2011) Patrick Kwan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacoresistant epilepsy: From pathogenesis to current and emerging therapies
- (2010) S. PATI et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Examining the Clinical Utility of Lacosamide
- (2010) Steve Chung et al. CNS DRUGS
- A Pooled Analysis of Lacosamide Clinical Trial Data Grouped by Mechanism of Action of Concomitant Antiepileptic Drugs
- (2010) John-Kenneth Sake et al. CNS DRUGS
- Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy
- (2010) Robert Fisher et al. EPILEPSIA
- Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy
- (2010) Maria Paola Canevini et al. EPILEPSIA
- Truly “Rational” Polytherapy: Maximizing Efficacy and Minimizing Drug Interactions, Drug Load, and Adverse Effects
- (2009) Erik St. Louis Current Neuropharmacology
- Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
- (2009) Patrick Kwan et al. EPILEPSIA
- The prevalence of epilepsy and pharmacoresistant epilepsy in adults: A population-based study in a Western European country
- (2008) Marie-Christine Picot et al. EPILEPSIA
- The clinical impact of pharmacogenetics on the treatment of epilepsy
- (2008) Wolfgang Löscher et al. EPILEPSIA
- Antiepileptic drug resistant rats differ from drug responsive rats in GABAA receptor subunit expression in a model of temporal lobe epilepsy
- (2008) Kerstin Bethmann et al. NEUROBIOLOGY OF DISEASE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started